[HTML][HTML] Augmented ERO1α upon mTORC1 activation induces ferroptosis resistance and tumor progression via upregulation of SLC7A11
Z Wang, H Zong, W Liu, W Lin, A Sun, Z Ding… - Journal of Experimental …, 2024 - Springer
Background The dysregulated mechanistic target of rapamycin complex 1 (mTORC1)
signaling plays a critical role in ferroptosis resistance and tumorigenesis. However, the …
signaling plays a critical role in ferroptosis resistance and tumorigenesis. However, the …
[HTML][HTML] Augmented ERO1α upon mTORC1 activation induces ferroptosis resistance and tumor progression via upregulation of SLC7A11
Z Wang, H Zong, W Liu, W Lin, A Sun… - … of Experimental & …, 2024 - ncbi.nlm.nih.gov
Background The dysregulated mechanistic target of rapamycin complex 1 (mTORC1)
signaling plays a critical role in ferroptosis resistance and tumorigenesis. However, the …
signaling plays a critical role in ferroptosis resistance and tumorigenesis. However, the …
Augmented ERO1α upon mTORC1 activation induces ferroptosis resistance and tumor progression via upregulation of SLC7A11.
Z Wang, H Zong, W Liu, W Lin, A Sun… - … of Experimental & …, 2024 - europepmc.org
Background The dysregulated mechanistic target of rapamycin complex 1 (mTORC1)
signaling plays a critical role in ferroptosis resistance and tumorigenesis. However, the …
signaling plays a critical role in ferroptosis resistance and tumorigenesis. However, the …
[HTML][HTML] Augmented ERO1α upon mTORC1 activation induces ferroptosis resistance and tumor progression via upregulation of SLC7A11
Z Wang, H Zong, W Liu, W Lin, A Sun… - … of Experimental & …, 2024 - jeccr.biomedcentral.com
The dysregulated mechanistic target of rapamycin complex 1 (mTORC1) signaling plays a
critical role in ferroptosis resistance and tumorigenesis. However, the precise underlying …
critical role in ferroptosis resistance and tumorigenesis. However, the precise underlying …
Augmented ERO1α upon mTORC1 activation induces ferroptosis resistance and tumor progression via upregulation of SLC7A11
Z Wang, H Zong, W Liu, W Lin, A Sun… - … of experimental & …, 2024 - pubmed.ncbi.nlm.nih.gov
Background The dysregulated mechanistic target of rapamycin complex 1 (mTORC1)
signaling plays a critical role in ferroptosis resistance and tumorigenesis. However, the …
signaling plays a critical role in ferroptosis resistance and tumorigenesis. However, the …
Augmented ERO1α upon mTORC1 activation induces ferroptosis resistance and tumor progression via upregulation of SLC7A11.
Z Wang, H Zong, W Liu, W Lin, A Sun… - … of Experimental & …, 2024 - search.ebscohost.com
Background: The dysregulated mechanistic target of rapamycin complex 1 (mTORC1)
signaling plays a critical role in ferroptosis resistance and tumorigenesis. However, the …
signaling plays a critical role in ferroptosis resistance and tumorigenesis. However, the …
Augmented ERO1α upon mTORC1 activation induces ferroptosis resistance and tumor progression via upregulation of SLC7A11.
Z Wang, H Zong, W Liu, W Lin, A Sun… - … of Experimental & …, 2024 - europepmc.org
Background The dysregulated mechanistic target of rapamycin complex 1 (mTORC1)
signaling plays a critical role in ferroptosis resistance and tumorigenesis. However, the …
signaling plays a critical role in ferroptosis resistance and tumorigenesis. However, the …
[PDF][PDF] Augmented ERO1α upon mTORC1 activation induces ferroptosis resistance and tumor progression via upregulation of SLC7A11
Z Wang, H Zong, W Liu, W Lin, A Sun, Z Ding, X Chen… - 2024 - jeccr.biomedcentral.com
Background The dysregulated mechanistic target of rapamycin complex 1 (mTORC1)
signaling plays a critical role in ferroptosis resistance and tumorigenesis. However, the …
signaling plays a critical role in ferroptosis resistance and tumorigenesis. However, the …